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Abstract
Background: The neural mobilization technique is a noninvasive method that has proved clinically effective in
reducing pain sensitivity and consequently in improving quality of life after neuropathic pain. The present study
examined the effects of neural mobilization (NM) on pain sensitivity induced by chronic constriction injury (CCI) in
rats. The CCI was performed on adult male rats, submitted thereafter to 10 sessions of NM, each other day, starting
14 days after the CCI injury. Over the treatment period, animals were evaluated for nociception using behavioral
tests, such as tests for allodynia and thermal and mechanical hyperalgesia. At the end of the sessions, the dorsal
root ganglion (DRG) and spinal cord were analyzed using immunohistochemistry and Western blot assays for neural
growth factor (NGF) and glial fibrillary acidic protein (GFAP).
Results: The NM treatment induced an early reduction (from the second session) of the hyperalgesia and allodynia
in CCI-injured rats, which persisted until the end of the treatment. On the other hand, only after the 4th session we
observed a blockade of thermal sensitivity. Regarding cellular changes, we observed a decrease of GFAP and NGF
expression after NM in the ipsilateral DRG (68% and 111%, respectively) and the decrease of only GFAP expression
after NM in the lumbar spinal cord (L3-L6) (108%).
Conclusions: These data provide evidence that NM treatment reverses pain symptoms in CCI-injured rats and
suggest the involvement of glial cells and NGF in such an effect.
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Background
The neural mobilization technique (NM) is a manual
therapy method used by physiotherapists to treat
patients with pain of neural origin, such as the compres-
sion of the sciatic nerve. NM is a noninvasive technique
that has been effective in improving the quality of life of
patients with neuropathic pain [1]-3]. In the literature,
there are several studies indicating that NM is clinically
effective against neuropathies [2,3]. However, the litera-
ture is scarce when surveyed on the possible mechanisms
involved. There are only a few articles showing that joint
mobilization it is able to decrease pain sensitivity in ani-
mals induced by neural injury or by capsaicin injection in
to ankle joint [4-6].
During the execution of body movements, the nervous
tissue protects the axons from tension and compression
forces incident on peripheral nerves [7]. It should be
stressed that the propagation of electrical impulses
depends also on the elasticity of normal nervous tissue,
as a normal component of its neurodynamics. The NM
technique aims to restore mobility and elasticity of the
peripheral nervous system and thus to improve the con-
ditions of patients with various neural injuries [8-11].
Numerous studies have demonstrated that glial cells,
both microglia and astrocytes, play a prominent role in
the nociceptive pathways. After a threshold stimulus,
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activated glial cells release inflammatory mediators such
as cytokines, prostaglandins, neurotrophic factors, ATP,
NO, and glutamate [12]. These inflammatory mediators
play a critical role in the development and maintenance
of central sensitization and hyperalgesia. Furthermore,
activated astrocytes have been shown to be a source of
nerve growth factor (NGF) after injury [13] or after in-
flammatory cytokine application in vitro [14]. There is
evidence that glial cells interact via neurotrophins with
neurons and express NGF [15,16].
NGF belongs to a still growing family of neurotrophic
molecules collectively called neurotrophins and that play
an important role on survival, growth and neural differ-
entiation [17]. NGF is produced and released by target
tissues and uptaken in a retrograde way to maintain
neuronal survival. Herzberg et al.. (1997) suggested the
involvement of NGF in the development of hyperalgesia
based on by the increase of mRNA coding for NGF in
both the sciatic nerve and in the DRG after constriction
of the sciatic nerve [18]. Neurotrophins also play import-
ant roles in chronic pain states caused by nerve injury
and inflammation [15,16,19]. In addition, neurotrophic
factors released by activated microglia have been
reported to generate a restoration of locomotor function
after LPS-induced inflammation [20].
The aim of our study is to verify if NM can improve
the pain-related behavior of rats after chronic constric-
tion injury (CCI). In addition, we attempted to identify
the possible changes of astrocytes, satellite cells and
NGF in the spinal cord and DRG of adult neuropathic
rats after NM.
Results
Effect of NM on mechanical and thermal hyperalgesia and
allodynia induced by CCI
Rats submitted to CCI developed a protective behavior
characterized by guarding of the ipsilateral hindpaw,
which is a sign of neuropathic pain. The CCI induced a
significant decrease of pain threshold (Figure 1A-C).
These alterations were detected as early as day 1 and
persisted for at least 1 month after surgery. The effects
of the manipulation resulted in modifying pain thresh-
olds (Figure 1). A decrease of mechanical hyperalgesia
and allodynia was observed starting in the second ses-
sion of neural mobilization (CCI-NM) when compared
to CCI animals that did not receive NM. This effect
remained constant for the next eight sessions (Figure 1
A,B). On the other hand, thermal hyperalgesia was
inhibited only after the fourth NM session, an effect that
remained constant until the last session (Figure 1C).
No significant difference of pain threshold was
observed in sham-operated animals that received NM
sessions (taken as control - sham-NM) during the whole
period analyzed (Figure 1), and no significant differences
of paw withdrawal threshold were observed on the
contralateral side of injury between measurements or at
any time post-lesion (data not shown). It is important to
point that all CCI animals that received NM sessions ex-
hibit a behavioral improvement, such as reduced guard-
ing behavior and recovery of limping. No difference was
observed in Naive or sham animals.
Effects of NM on NGF and GFAP expression
A single NGF-positive band was observed in DRG and
spinal cord extracts from all groups analyzed. Figure 2
shows an increase of NGF protein levels on the ipsilat-
eral side from experimental animals in the DRG (CCI
and CCI NM) and spinal cord when compared to the
same side from naive rats, taken as controls and desig-
nated as 100%.
Regarding DRG, densitometric analysis revealed an in-
crease of NGF expression in animals with CCI (111%
above the control) when compared to naive animals and
a return to control levels in rats that received NM treat-
ment (CCI-NM) (Figure 2A). No statistical differences of
NGF expression were observed between sham- NM and
naive or between sham and sham-NM animals (data not
show). On the other hand, no difference was observed
when the lumbar spinal cord was analyzed (figure 2B).
Similar results were observed when we analyzed the
GFAP-positive band in the DRG and lumbar spinal cord
tissue described above. Our results showed an increase
Figure 1 Effect of neural mobilization on pain threshold induced by CCI in rats. Pain thresholds as measured by the test of Randall & Selitto
(A), von frey test (B), expressed in grams, and thermal hyperalgesia, assessed by Hargreaves test (C), expressed in seconds. Measurements were
determined before (base line- BL), 14 days after and at different intervals after NM sessions. The results represent the mean± SEM of 10 animals
per group. * P <0.05 for comparison between groups: CCI and CCI NM.
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of GFAP levels (68% for DRG and 108% for spinal cord,
above the control) after CCI injury when compared to
naive animals and a return to normal levels after NM
treatment (CCI-NM) (Figure 3). No difference was
observed between naive and sham-NM or between sham
and sham-NM (data not show). No differences were
observed for β-actin between control and experimental
sides at any of the time points tested (Figures 2 and 3).
Double-labeling immunofluorescence for NGF and GFAP
in the DRG after NM in neuropathic rats
We also examined the immunostaining for NGF (Figure 4)
and GFAP (Figure 5) in the lumbar (L4) DRG from CCI,
sham and naive rats. Immunofluorescence was performed
in the ipsilateral (right) sides of the CCI animals (with or
without NM) and compared to the ipsilateral side of
sham-operated rats or the same side naive animals (taken
as controls).
A moderate number of cells labeled for NGF-
immunoreactivity (NGF-IR) were observed in the DRG
of naive and sham rats (Figure 4). After CCI, there was a
marked increase in the number of NGF-IR cells in the
ipsilateral side. We observed a decrease of NGF-IR in
animals that received NM treatment in relation to un-
treated rats (Figure 4).
Regarding GFAP, we observed an increase of cells la-
beled for GFAP-IR in the DRG after CCI when com-
pared with naive animals and a reduction after NM
treatment when compared to CCI animals (Figure 5).
Discussion
The aim of our study was to evaluate the effects of NM
in behavioral improvement in neuropathic rats, and to
Figure 2 Densitometric analysis of NGF protein levels in the DRG (A) and spinal cord (B). The normalized average between sham and
experimental groups (CCI) is reported. Data for naive animals were taken as 100%. Data are reported as mean± SEM of 6 animals per group. * P <0.05
compared to CCI animals.
Figure 3 Densitometric analysis of GFAP protein levels in the DRG (A) and spinal cord (B). The normalized average between sham and
experimental groups (CCI) is reported. Data for naive animals were taken as 100%. Data are reported as mean± SEM of 6 animals per group. * P <0.05
compared to CCI animals.
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evaluate NGF and GFAP levels in the DRG and spinal
cord after NM.
Behavioral data confirmed the onset of neuropathic
pain syndrome 3 days after CCI, which stabilized by the
14th day after injury, as shown by reduced mechanical,
thermal and allodynic thresholds in the ipsilateral side of
injury. We demonstrated those ten NM sessions each
other day restored mechanical, thermal and allodynic
sensitivity, as well as all behavior parameters that were
associated with the neuropathic condition.
There is a growing body of evidence that a unilateral
nerve injury induces contralateral changes. The effect of
the unilateral peripheral nerve lesion on contralateral
non-lesioned structures was reviewed by many authors.
In general, the responses to contralateral injuries are
usually in smaller magnitude and with a briefer time
course compared to ipsilateral changes [21,22]. However,
our results demonstrated an effect at the unilateral nerve
injury which corroborates with others studies showing
the same response [23-27]. Methodological variables
could account for this discrepancy, such as different
strains of rats, different methodologies or different su-
ture material used for different authors [28].
The impact of halothane anesthesia does not interfere
with behavior responses, since the nociceptive experi-
ments were realized on subsequent day after NM ses-
sions. In addition, studies demonstrated that from
inhalation anesthetics, halothane was able to decrease
nociceptive reactions (returned to basal levels) faster
than other inhalatory anesthesics (enflurane, isoflurane,
and desflurane) [29]. Furthermore, studies have shown
that the use of inhalational anesthetic during nine ses-
sions of physical therapy in rats did not change expres-
sion of glial cells markers [4]. Suggesting that this
anesthetic does not influence in chronic models of
sensitization [30,31].
Our behavioral data are in agreement with studies show-
ing that NM is efficient as a therapeutic approach in clinical
applications [1,3,11]. Studies realized recently, demon-
strated the reversion of hyperalgesia, as well as nerve regen-
eration and decreased of glial cells expression such as
microglia and astrocytes in the spinal cord, after joint
mobilization in a model of sciatic nerve crush injury [4]. In
addition, Malisza, K.L. et al. (2003) examine neuronal acti-
vation in the spinal cord due the secondary hyperalgesia
resulting from intrajoint capsaicin injection [32].
Figure 4 Double-labeling of NGF and NeuroTrace in the ipsilateral DRG after CCI injury. Naive, Sham (control), CCI (14 days after injury)
and animals treated with neural mobilization (CCI NM) were analyzed. Double immunofluorescence shows NGF (red) and NeuroTrace (green).
Note that NGF expression after neural mobilization decreased when compared to CCI. Scale bar, 50 μm.
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On the other hand, studies realized by Vicenzino et al.
(1998) and Sterling et al. (2001) using spinal manual
therapy, showing a hypoalgesia effect but no influence
on thermal hyperalgesia, suggesting an effect in inhibi-
tory pathway from the dorsal periaquedutal gray area
[33,34].
In this regard, we also evaluated the levels of NGF and
GFAP in the DRG and spinal cord after NM treatment
in CCI-injured animals. We demonstrated an increase of
NGF expression in CCI-injured rats, and a decrease to
normal levels after NM treatment in DRG tissues. On
the other hand, no difference was observed in lumbar
spinal cord tissue analyzed. This indicates that the in-
crease of NGF occurs at time points that are coincident
with its role in pain-related behaviors, suggesting that
NGF is involved in the nociceptive effects induced by
neuropathic pain. Our data are in agreement with sev-
eral studies showing that NGF injections by systemic
and peripheral routes induce nociception [15-17,19]. In-
deed, NGF seems to be a critical mediator of all types of
pain, including short-term pain [35], surgical pain [36],
inflammatory pain [37] visceral pain [38] and neuro-
pathic pain [19,38].
The pain induced by peripheral inflammation or
neuropathic pain is currently being linked to the involve-
ment of glial cells or satellite cells located in the spinal
cord and DRG, respectively [39,40]. Our studies demon-
strate through Western Blot technique an increase in
optical density of the bands marked with astrocytes and
satellite cells (GFAP) in spinal cord and DRG, respect-
ively, in animals with chronic constriction sciatic nerve
(CCI). Animals with CCI and treated with NM, we
observed a decrease in GFAP-IR in both tissue analyzed
and a reversal of hyperalgesia and allodynia. Our find-
ings corroborate Garrison et al.. 1991 showed an
increased density of these cells, specifically astrocytes, in
the spinal cord after induction of ligatures in the sciatic
nerve [41]. Nerve injury activates glial cells, which pro-
duce and release inflammatory mediators that act on
glial cells and neurons, sensitizing the dorsal horn and
facilitating pain transmission [39,42]. Here we demon-
strated an increase of NGR-IR and GFAP-IR in DRG
Figure 5 Double-labeling of GFAP and NeuroTrace in the ipsilateral DRG after CCI injury. Naive, Sham (control), CCI (14 days after injury)
and animals treated with neural mobilization (CCI NM) were analyzed. Double immunofluorescence shows GFAP (red) and NeuroTrace (green).
Note that GFAP expression after neural mobilization decreased when compared to CCI. Scale bar, 100 μm.
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neurons after CCI-injury, which was decreased after NM
treatment. This suggests an involvement of NGF and
glial cells in our experimental model, which remains to
be fully understood. Our observations were generally
consistent with the literature regarding the time course
and localization of astrocytes and satellite cells activation
[43]. Nerve injury and inflammation have been shown to
lead to proliferation and hypertrophy of satellite cells,
and to upregulate other molecules, including neurotro-
phins, tumor necrosis factor α, and functional gap junc-
tions [17,43].
Glial cells appear to be a pivotal component of the
neuroinflammatory process, and it is known that this
type of cell, in the spinal cord, reacts to peripheral nerve
injury and inflammation by activation, proliferation, and
by releasing messengers that contribute to pathological
pain. Glial cells participate in synaptogenesis and main-
tenance of synaptic activity and expression of receptors,
transporters, ionic channels, at least through the release
of neurotrophins such as NGF [44-46].
In summary, our data reveal a reversal of the NGF and
GFAP increase in DRG by NM treatment in CCI ani-
mals. On the other hand, we observed the involvement
of GFAP only in spinal cord. We also demonstrated that
NM sessions are able to improve behavioral responses,
providing evidence of the importance of NM in restoring
the changes caused by CCI injury, which contribute to
neuropathic pain behavior. These findings suggest that
NM reverses the nociceptive behavior of neuropathic
animals, and suggest the involvement of glial cells and
NGF in such an effect.
Methods
Animals
Male Wistar rats, weighing between 180 and 220 g (ca.
2 months-old) were used in all experiments. They were
singly housed and maintained on a 12:12 h light/dark
cycle. The rats were adapted to the experimental envir-
onment three days before the experiments started. All
animals were tested during the light cycle at the same
time of the day (9:00 am–12:00 a.m.). All procedures
were approved by the Institutional Animal Care Com-
mittee of the University of São Paulo (protocol number
26 – book number 02/2010). Efforts were made to
minimize the number of animals used and their
suffering.
Surgical procedure
Chronic constriction injury - (CCI)
For the induction of neuropathic pain, chronic constric-
tion of the sciatic nerve was performed as described by
Rats were anesthetized with halothane (Cristalia, Brazil)
[47]. The common sciatic nerve was exposed at the level
of the middle of the thigh by blunt dissection through
the biceps femoris. Proximal to the sciatic trifurcation
(about 7 mm), the nerve was freed of adhering tissue
and 4 ligatures (4.0 chromic gut- Paramed) were tied
loosely around it with about 1 mm spacing. Great care
was taken to tie the ligatures, such that the diameter of
the nerve was seen to be just barely constricted. The in-
cision was closed in layers. In sham-operated rats the
sciatic nerve was exposed but left unaffected and served
as a control. Each rat was closely observed during the
recovery from anesthesia and then returned to the home
cage and was observed carefully during the following 24
hours. During the 5 day-period after CCI the walking
and cage exploration, degree of limping, and conditions
of the hindpaw, including signs of excessive grooming or
autotomy, were all closely observed.
Neural Mobilization Technique – (NM)
The NM technique used has been described by Butler
(1989). Briefly, to perform the technique rats were
anesthetized with halothane with a continuous flow of
medicinal oxygen throughout the procedure (5 ml/L)
[48]. After anesthesia, the animals were positioned in the
left lateral position to mobilize the right side (ipsilateral
to CCI). The right knee joint was then positioned in full
extension (at 0 degrees) and remained so throughout the
session. Moreover, the right hip joint was bent between
70 to 80 degrees with the knee in extension until obtain-
ing a small resistance induced by stretching the muscles
from compartimentum posterius femoris (M. biceps
femoris, M. semimembranosus and M. semitendinosus).
After the therapist fell the resistance, the angle of this
joint it is interrupted. At this time the ankle joint, will
be angled between 30 to 45 degrees, using the same
principle, as described before. After all joints are posi-
tioned with minimal resistance of those muscles, oscilla-
tory movements are initiated. The right ankle joint was
manipulated in dorsi-flexion (30 to 45 degrees) by ap-
proximately 20 oscillations per minute during 2 minutes,
followed by a 25-second pause for rest. The treatment
took place for ten minutes, and in the last minute the
cervical spine was fully flexed, with the purpose of ten-
sioning the entire neuraxis [49]. Treatment with the NM
technique started 14 days after injury or sham animals,
and the NM sessions was applied every other day, for a
total of 10 sessions.
Behavioural experiments
The development of neuropathic pain symptoms in the
hindpaw was evaluated by testing mechanical (Randall
and Selitto test) and thermal hyperalgesia (Hargreaves
test) [50,51] and allodynia (Von Frey hair test). Those
sensory tests were used in light of literature data show-
ing that CCI induces both mechanical and thermal
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hyperalgesia and allodynia of the ipsilateral hindpaw
[52].
Paw withdrawal was measured before surgery (Base-
line-BL), 14 days after surgery (to confirm neuropathic
pain), and intercalated with NM sessions to avoid the
impact of halothane anesthesia on subsequent pain test-
ing. All behavioral tests were double-blind.
Mechanical hyperalgesia (Randall and Selitto test)
An Ugo-Basile pressure apparatus [51] was used to as-
sess pressure pain thresholds prior to surgery and again
at different times thereafter. Testing was blind in regard
to group designation. Briefly, increasing force (16 g/s)
was applied to the right hindpaw. The force needed to
induce paw withdrawal was recorded as the pain thresh-
old. To reduce stress, the rats were habituated to the
testing procedure the day before the experiment.
Thermal hyperalgesia (Hargreaves test)
The Hargreaves test, which measures response latencies to
hindpaw thermal stimulation [50] was used. Each rat was
placed in a clear plastic cylinder (24 cm [H] × 16.5 cm [D])
atop a glass floor in a temperature controlled room
(28± 1°C) and allowed to adapt to this environment for
30 min before testing. Rats were first habituated to the ex-
perimental context (room and apparatus) for 2 consecu-
tive days for 45 minutes/day. BL paw withdrawal values
were calculated from an average of two to three consecu-
tive withdrawal latencies of the right hindpaw measured at
10-min intervals. Voltage to the light source was adjusted
to yield BL latencies ranging 15–20 s. A cut-off time of
40 s was imposed to avoid tissue damage.
Low threshold mechanical allodynia (von Frey test)
The von Frey test [53] was used to assess low-threshold
mechanical pain thresholds prior to surgery and again at
different times thereafter. Testing was blind in regard to
group designation. This test was performed as previously
described [54]. Briefly, a logarithmic series of 10 cali-
brated Semmes-Weinstein monofilaments (von Frey hair
test, Stoelting, USA) were applied to the middle of the
plantar surface of the right hindpaw, for a maximum of
10 s to determine the threshold intensity of the stiffness
stimulus required to elicit a paw withdrawal response.
Log stiffness of the hairs is determined by ranges start-
ing at 3.61 N (0.407 g); (3.61 (0.407 g.); 3.84 (0.692 g.);
4.08 (1.202 g.); 4.17 (1.479 g.); 4.31 (2.041 g.); 4.56
(3.630 g.); 4.74 (5.495 g.); 4.93 (8.511 g.); 5.07(11.749 g)
and reaching 5.18 (15.136 g.). Baseline assessment was
initiated with the 2.041-g hair. In the event of paw with-
drawal, the same hair was again presented 60–90 s later.
If the response was elicited again, the 0.407 g monofila-
ment was presented. In the absence of a paw withdrawal
response to the 0.407 g stimulus, the next stronger
monofilament was presented (0.692 g). The monofila-
ment that elicited a clear response was recorded, and
was presented once again 30–60 s later. If the animal
withdrew its paw in two consecutive trials with the same
stiffness value, no further von Frey hairs were tested.
However, in the absence of a response to the initial
2.041-g monofilament, presentation of monofilaments
continued in ascending order until two consecutive
responses were elicited from the same monofilament. All
single responses were recorded, but assessment was
complete only after two consecutive responses to the
same stimulus. Failure to respond to the strongest
stimulus (15.136 g) was considered to be the cut-off
value. Response to the weakest stimulus (0.407 g) was
considered to be the lower cut-off value. To reduce
stress, rats were adapted to the experimental environ-
ment daily for 3 days before the experiments.
Immunoblotting
Western blotting analyses were performed on samples from
individual animals. Neuropathic (CCI), Sham and naive rats
were sacrificed by decapitation under light halothane
anesthesia and the ipsilateral DRG (from L3-L6) and lum-
bar spinal cord (L3-L6) were quickly removed and homoge-
nized in an extraction buffer containing 100 mM Tris, pH
7.4, 10 mM EDTA, 2 mM PMSF, and 10 μg/mL aprotinin.
After extraction, the homogenates were centrifuged at
11.5 g for 20 min and the protein concentration of the
supernatant was determined using the Bradford protein
assay with albumin as a standard (Bio-Rad, USA) [55].
Samples containing 75 μg protein were loaded on a 12%
acrylamide gel and electrotransferred to nitrocellulose
membranes using a Bio-Rad miniature transfer apparatus
during 1.5 h at 120 V. After transfer, the membranes were
treated for 2 h at room temperature with a blocking solu-
tion containing 5% powdered milk, washed and incubated
overnight at 4°C with rat monoclonal antibodies against rat
NGF (F30, 1:1000; Santa Cruz Biotechnology, INC) (Wu
et al., 2007) and against mouse GFAP (1:1000; Sigma, St.
Louis, MO) (Chacur et al., 2004b) . The membranes were
then washed and incubated for 2 h at room temperature
with a peroxidase-conjugated, anti-rat secondary antibody,
diluted 1:5000 (ZIMED Laboratories Inc) and an anti-
mouse secondary antibody (GE Healthcare, USA). β-actin
was used as an endogenous control (1:10000, Sigma). The
specifically bound antibody was visualized using a chemolu-
minescence kit (Amersham Biosciences). The blot was ana-
lyzed densitometrically using NIH-Scion Image 4.0.2 and
quantified by optical densitometry of the developed autora-
diographs (Scion Corporation, USA).
Immunofluorescence and image analysis
After the appropriate survival time, the animals were
deeply anesthetized with ketamine (0.1 mL/kg) and
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xylazine (0.1 mL/kg) and perfused through the heart
with phosphate-buffered saline and 4% paraformalde-
hyde in 0.1 M phosphate buffer (PB), pH 7.4. The DRG
from the lumbar spinal cord (L4) were removed and
post-fixed for 4 h in 4% paraformaldehyde. The DRG
were transferred to a 30% sucrose solution in PB to en-
sure cryoprotection, which lasted for 48 h, and trans-
verse sections of DRG were performed by embedding it
in OCT compound, freezing and then cutting (12 μm-
sections) on a cryostat. DRG sections were incubated
with a mouse monoclonal antibody against NGF (Santa
Cruz Biotechnology, INC) and GFAP (Sigma, St. Louis,
MO) diluted 1:1000 in PB containing 0.3% Triton X-100
and 5% normal goat serum. Incubations with the pri-
mary antibody were conducted overnight at 24°C; sec-
tions were then washed three times for 10 min each in
PB and incubated with a tetramethyl rhodamine isothio-
cyanate - TRICT – conjugated affinipure goat anti-
mouse igG (Jackson ImmunoResearch , USA) diluted
1:100 in PB for 2 h at 24°C. After several washes in PB,
the same sections were incubated with Neurotrace (500/
525 green fluorescent Nissl stain, Molecular Probes) at
1:1000 in PB during 30 minutes for neuronal identifica-
tion. Controls of the experiments consisted of the omis-
sion of primary antibodies, and no staining was observed
in these cases. After washing, the tissue was mounted
using VectaShield (Vector Laboratories, Burlingame, CA).
Slides were analyzed in a fluorescence microscope
coupled to a digital camera. Figures were mounted with
Adobe Photoshop CS. Manipulation of the images was
restricted to threshold and brightness adjustments of the
whole image. It should be stressed that the antibodies
used here has been extensively tested and characterized
[26,56-58]. Regarding immunofluorescence analyzes, we
used as qualitative test, the immunoblotting assays was
used as quantitative test.
Statistical analysis
Data were statistically analyzed by analysis of variance
(ANOVA) and sequential differences between means
were tested by Tukey contrast analysis at P< 0.05 [59].
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